CYP46A1 and early-onset autosomal dominant Alzheimer disease: In summary, the ACAT and CYP46A1 manipulations suggest that biosynthesis of the CE cargo of LDs can be harmful, contributing to the pathogenesis of Alzheimer’s disease.